Intriguingly, the CCA marker KRT19 and the PROX1 targets PRRX1 and PPARG exhibited a negative correlation with PROX1 expression in tumor tissue (Fig. 7b), suggesting that PROX1 could regulate liver cancer plasticity and HCC versus CCA fate. The gene discussed is KRT19; the disease is cholangiocarcinoma.